Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US6723748B2 · kind B2 · utility
1Cited by
18References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 2002 |
| Grant date | Apr 20, 2004 |
| Priority date | — |
| Expiry date | Feb 5, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C405/0025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is the use of cloprostenol and fluprostenol analogues in combination with carbonic anhydrase inhibitors for the treatment of glaucoma and ocular hypertension and ophthalmic compositions therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.